Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

The Nucleolus

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...

Reaction Rate

Reaction Rate

The rate of reaction is the change in the amount of a reactant or product per unit time. Reaction rates are therefore determined by measuring the time dependence of some property that can be related to reactant or product amounts. Rates of reactions that consume or produce gaseous substances, for example, are conveniently determined by measuring changes in volume or pressure.
The mathematical representation of the change in the concentration of reactants and products, over time, is the rate...

Voltaic/Galvanic Cells

Voltaic/Galvanic Cells

Spontaneous Chemical Reactions
Spontaneous redox reactions occur abundantly in nature. The chemical reaction occurring in a disposable AA battery powering our remote controls is one such example of a spontaneous redox reaction. Another example is the immersion of coiled copper wire into an aqueous silver nitrate solution. The reaction shows a gradual, visually impressive color change from colorless to bright blue and the formation of a grey precipitate on the copper wire. In this experiment,...

Measuring Reaction Rates

Measuring Reaction Rates

Polarimetry finds application in chemical kinetics to measure the concentration and reaction kinetics of optically active substances during a chemical reaction. Optically active substances have the capability of rotating the plane of polarization of linearly polarized light passing through them—a feature called optical rotation. Optical activity is attributed to the molecular structure of substances. Normal monochromatic light is unpolarized and possesses oscillations of the electrical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Editorial: Aging, peripheral inflammation, and neurodegeneration.

Frontiers in aging neuroscience·2024

Same author

Prevalence and Impact of Cerebral Microbleeds on Clinical and Safety Outcomes in Acute Ischaemic Stroke Patients Receiving Reperfusion Therapy: A Systematic Review and Meta-Analysis.

Biomedicines·2023

Same author

Nervous system-related tropism of SARS-CoV-2 and autoimmunity in COVID-19 infection.

European journal of immunology·2023

Same author

Prospective analyses of alertness, sleep, and fitness to drive one year after de novo multiple sclerosis diagnosis.

Multiple sclerosis and related disorders·2023

Same author

Editorial: Insights in multiple sclerosis and neuroimmunology: 2021.

Frontiers in neurology·2023

Same author

Editorial: Telemedicine during and beyond COVID-19, volume II.

Frontiers in public health·2022

Search research articles

Related Experiment Video

Updated: Jan 25, 2026

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

Progressive multifocal leukoencephalopathy.

Robert Weissert¹

¹Department of Neurology, Geneva University Hospital, Micheli-du-Crest 24, 1211 Geneva 14, Switzerland. robert.weissert@hcuge.ch

Journal of Neuroimmunology

|October 13, 2010

Summary

Progressive multifocal leukoencephalopathy (PML) is a fatal CNS infection by JC virus. Immune Reconstitution Inflammatory Syndrome (IRIS) can improve PML outcomes but poses risks, requiring specialized patient care.

Area of Science:

Neuroimmunology
Infectious Diseases
Oligodendrocyte Biology

Background:

Progressive multifocal leukoencephalopathy (PML) is a severe opportunistic infection of the central nervous system (CNS) caused by JC virus.
PML affects oligodendrocytes and is associated with conditions like HIV/AIDS, malignancies, and immunosuppression from therapies like monoclonal antibodies (mAbs).
The natural prognosis of PML is typically fatal within months, though Immune Reconstitution Inflammatory Syndrome (IRIS) can alter this course.

Purpose of the Study:

To review the understanding of PML, its association with JC virus, and the emerging role of PML-IRIS.
To highlight the complexities in managing PML-IRIS, emphasizing the need for specialized knowledge in JC virus biology and patient care.
To explore the potential involvement of JC virus in other neurological conditions and cancers.

More Related Videos

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

Multifocal Electroretinograms

Multifocal Electroretinograms

Published on: December 4, 2011

Related Experiment Videos

Last Updated: Jan 25, 2026

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

Multifocal Electroretinograms

Multifocal Electroretinograms

Published on: December 4, 2011

Main Methods:

Literature review of PML and JC virus pathogenesis.
Analysis of clinical observations regarding PML and PML-IRIS.
Synthesis of current knowledge on opportunistic infections in immunocompromised patients.

Main Results:

PML is a JC virus infection of oligodendrocytes, often fatal, but survival is possible with PML-IRIS.
PML-IRIS involves an immune response to JC virus, which can be beneficial but also lead to severe neurological complications.
JC virus may play a role in other diseases, warranting further investigation.

Conclusions:

PML management, particularly PML-IRIS, demands specialized expertise due to the complex interplay between JC virus and the immune system.
Further research into JC virus biology and its broader implications for human health, including cancer, is crucial.
Understanding JC virus and its associated syndromes like PML-IRIS is evolving and may significantly change future medical perspectives.